Chargement en cours...
Arsenic trioxide for the treatment of acute promyelocytic leukaemia
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the role of arsenic trioxide (ATO) for treating patients with acute promyelocytic leukaemia in comparison with regimens without ATO.
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463851/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008425.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|